- Scrip Originals
- Featured Topics
Statens Serum Institut
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Statens Serum Institut
GlaxoSmithKline has published results from its latest Phase IIb trial of its investigational tuberculosis vaccine that show a subunit vaccine can reduce pulmonary TB, possibly leading the way for the first new vaccine for TB in over 90 years.
- Academic and Research Institutions